Page last updated: 2024-12-11

dioleoylphosphatidic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dioleoylphosphatidic acid: RN given refers to (Z)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dioleoyl phosphatidic acid : A phosphatidic acid in which the phosphatidyl acyl groups are both oleoyl. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9547172
CHEBI ID60427
SCHEMBL ID3817083
MeSH IDM0113774

Synonyms (14)

Synonym
dioleoyl phosphatidic acid
dioleoylphosphatidic acid
CHEBI:60427 ,
pa(18:1(9z)/18:1(9z))[u]
pa(18:1/18:1)[u]
1,2-dioleoylglycerol-3-phosphate
3-(phosphonooxy)propane-1,2-diyl (9z,9'z)bis-octadec-9-enoate
EPITOPE ID:136905
gtpl5512
[1-[(z)-octadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (z)-octadec-9-enoate
SCHEMBL3817083
[2-[(z)-octadec-9-enoyl]oxy-3-phosphonooxypropyl] (z)-octadec-9-enoate
Q27077072
pa 18:1_18:1

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"It is well established that the circulation half-life of liposomes increases with increasing dose."( Influence of dose on liposome clearance: critical role of blood proteins.
Chonn, A; Cullis, PR; Oja, CD; Semple, SC, 1996
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
1,2-bis(octadec-9-enoyl)phosphatidic acidA phosphatidic acid (36:2) in which both acyl groups are specified as octadec-9-enoyl.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1345173Human GPR63 (Class A Orphans)2003Cellular signalling, Apr, Volume: 15, Issue:4
Sphingosine 1-phosphate and dioleoylphosphatidic acid are low affinity agonists for the orphan receptor GPR63.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (58)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (22.41)18.7374
1990's18 (31.03)18.2507
2000's20 (34.48)29.6817
2010's5 (8.62)24.3611
2020's2 (3.45)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.38 (24.57)
Research Supply Index4.09 (2.92)
Research Growth Index4.47 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other59 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]